Paratek Pharmaceuticals (PRTK) executive Woodrow received 101,250 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Adam Woodrow (executive at Paratek Pharmaceuticals Inc., PRTK) reported that they received 101,250 shares on Mar 15, 2022. After these transactions the filing shows 563,579 shares held directly.
- Reporting person
- Woodrow Adam
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 15, 2022 | Grant or award (A) | Common Stock1 | +101,250 | - | - | 563,579 direct |
Holdings before and after
- Common Stock: 462,329 to 563,579 direct
Footnotes from the filing
- 1. Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest as to 15/45 of the shares subject to the restricted stock units on December 10, 2022, and on the same calendar date of each successive year thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Woodrow report in this PRTK Form 4?
Adam Woodrow (executive at Paratek Pharmaceuticals Inc., PRTK) reported that they received 101,250 shares on Mar 15, 2022. After these transactions the filing shows 563,579 shares held directly.
How many PRTK shares does Woodrow hold after this filing?
The filing shows 563,579 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for PRTK
Earlier insider filings at PRTK
- Mar 24, 2022SEC Form 4: Loh Evan was granted 236,250 shares, increasing direct ownership by 26% to 1,149,534 units
- Mar 24, 2022SEC Form 4: Haskel William M. was granted 67,500 shares, increasing direct ownership by 20% to 407,659 units
- Mar 24, 2022SEC Form 4: Brenner Randall B. was granted 67,500 shares, increasing direct ownership by 27% to 321,030 units
- Mar 24, 2022SEC Form 4: Bigham Michael was granted 202,500 shares, increasing direct ownership by 23% to 1,093,282 units
- Feb 18, 2022SEC Form 4: Stein Jeffrey was granted 20,000 shares, increasing direct ownership by 56% to 55,625 units
Quantisnow market dataNASDAQ
PRTK
Paratek Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for PRTK
Full PRTK profile on Quantisnow Follow PRTK and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time